Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 55154-6635

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 55154-6635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Non-fatal Myocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (Figure 1)

A line chart comparing the cumulative incidence percentage over 3.5 years for Atorvastatin versus placebo. The solid line represents Atorvastatin, and the dashed line represents placebo, showing different cumulative incidence trends over time.*

FDA Label Image

Figure 2: Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) (Figure 2)

A line graph showing cumulative hazard percentages over a follow-up period of up to 5 years. The graph compares two groups: Placebo (dashed line) and Atorvastatin (solid line), illustrating the time to first primary endpoint through four years of follow-up. The hazard ratio (HR) and p-value are indicated on the graph.*

FDA Label Image

Figure 3: Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (Figure 3)

A Kaplan-Meier survival curve chart comparing two dosages of Atorvastatin, 10 mg and 80 mg, over a 5-year period. The y-axis represents the percentage of subjects experiencing a cardiovascular event, while the x-axis represents time to the first major cardiovascular endpoint in years. The chart includes hazard ratio (HR) statistics indicating lower event rates with the 80 mg dose.*

FDA Label Image

Structural Formula (Structure)

Chemical structure of Atorvastatin Calcium showing molecular components including the calcium ion (Ca2+) and the atorvastatin molecule with its various functional groups. The diagram depicts the detailed molecular configuration of this active ingredient.*

FDA Label Image

D4ec0525 42cb Db55 E053 2995a90a607d 00

Label for Atorvastatin Calcium Tablets USP 40 mg, film-coated tablets in a package of 10 tablets. Includes storage instructions, a warning that the unit dose package is not child resistant and is intended for institutional use only, and distribution information by Cardinal Health and American Health Packaging. The label lists the NDC number and manufacturer details.*

FDA Label Image

D4ec0525 42cb Db55 E053 2995a90a607d 01

Atorvastatin Calcium 20 mg film-coated tablets in a unit dose package containing 10 tablets. Label includes storage instructions, a dosage note referring to the product insert, warnings about child resistance and packaging integrity, and distributor information listing American Health Packaging and Cardinal Health.*

FDA Label Image

D4ec0525 42cb Db55 E053 2995a90a607d 02

Atorvastatin Calcium film-coated tablets 10 mg unit dose package label with 10 tablets. Includes barcode, NDC 55154-6635-0, storage instructions, warnings, and distribution information for Cardinal Health 107, LLC and American Health Packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.